HomeVideosTreatmentProjectsFriends
Site Wide RSS Feed


Home > Blog > April 2012
Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
Oakland Raiders linebacker Rolando McClain turned to stem- cell therapy to deal with the aches and pains that come with being a professional football player, the Mobile Press-Register reported Sunday.

Former-Alabama-football-players-get-stem-cell-injections.jpg

 
"It feels a lot better," McClain told the newspaper, adding he has been able to work out with hardly any pain at all."

According to the newspaper, McClain, who missed only one game last season but was hampered by knee pain and an ankle injury, had stem cells taken from his own fat and injected into his knee and leg. McClain credits the procedure for helping him do what he needs to do to prepare for the 2012 season.
 
Jason R. Williams, the radiologist who performed the procedure in Alabama, called the experimental therapy "the future of medicine." However, the newspaper also reported that the FDA has warned consumers about the possible pitfalls of stem-cell treatments.
 
"There is a potential safety risk when you put cells in an area where they are not performing the same biological function as they were when in their original location in the body," said Stephanie Simek, deputy director of the FDA's Office of Cellular, Tissue and Gene Therapies, in a statement.

EDITOR'S NOTE: What the FDA will never tell you is that the "safety risk" of the expensive knee surgeries which the FDA has approved are far far more dangerous to a player's career than stem cell therapy.    ---Don Margolis

Don Margolis

 
The newspaper reported that McClain and fellow University of Alabama product Marquis Maze have sought the treatment. Peyton Manning, who recently joined the Denver Broncos after missing the 2011 season with neck issues, reportedly also had a similar procedure outside of the country.
 
Posted: 4/22/2012 4:13:01 PM by Don Margolis | with 0 comments


Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
Pitcher-hopes-stem-cell-procedure.jpg

When pitching in the Dominican Republic, C.J. Nitkowski said he felt he was back to his normal self on the mound


STORY HIGHLIGHTS
  • C.J. Nitkowski was a first-round draft pick in 1994
  • He hasn't played in the major leagues since 2005
  • He had a controversial stem cell procedure last year in his injured shoulder
  • After a good outing in a winter league, he's waiting for a big league team to call

Alpharetta, Georgia (CNN) -- At 39 years old, Christopher John Nitkowski really has no business trying to pitch in the major leagues. In the harsh reality of professional sports, he's a has-been.
Just don't tell him that.

The former first-round draft pick last pitched for the Washington Nationals in 2005 after a 10-season career spent mostly as a left-handed reliever.
 
"You go as long as you can," he told CNN. "I had a good friend tell me, 'Man, just make them tear the uniform off of you. You can do whatever you're gonna do for the rest of your life. You can't play baseball forever.'"

doctor-injects-(1).jpg

A doctor injects C.J. Nitkowski's stem cells into his injured shoulder
 
In the middle of the 2011 baseball season Nitkowski announced in a first-person article for Sports Illustrated that he would try a comeback. After his brief major league appearance in 2005, he pitched subsequent years for one team in Japan and three in South Korea.
 
This time, he wrote, he would agree to a risky medical experiment that would involve injecting his own stem cells into his injured pitching shoulder, which he hurt in an initial comeback attempt last spring.
 
Notice how Big Media ALWAYS calls it "risky" or "unproven" without any proof of anything negative.  It is the law in the USA:  "Thou shalt not irritate Big Pharma by telling the truth about Repair Stem Cells." (RSC)

Nitkowski was following the path of 37-year-old Bartolo Colon, who in late 2010 went through the same procedure. Colon wound up restored to health and pitched credibly for the New York Yankees in 2011.

a-pitch-for-one-last-season.jpg

Nitkowski telephoned the doctor who treated Colon and agreed to pay about $3,000 for the procedure.
Nitkowski and the physician, Dr. Joseph Purita, agreed to CNN's request to follow the procedure and report on the outcome, no matter what that turned out to be.
 
In late August, Nitkowski went to Purita's Florida office and watched as some of his own stem cells were extracted from fatty tissue around his waist. The stem cells were then spun in a centrifuge and emerged as something called platelet rich plasma (PRP), which athletes have been using in recent years to restore their health.
 
Nitkowski returned several weeks later for a follow-up PRP injection. No human growth hormones, which are a banned substance in major league baseball, were used.
 
Both Nitkowski and Purita told CNN they were well aware of the risks.
 
"We really don't have a good uniform idea of what constitutes platelet rich plasma," Purita told CNN. "I mean, what is it? You could ask 10 doctors and they're going to give you 10 different answers. We really need to get together and form an idea as to what it is."
 
One doctor contacted by CNN says the whole process is essentially worthless.
 
"There are many, many misstatements, direct inaccuracies and errors in the way that growth factors and stem cells are portrayed," Dr. George Daley, president of the International Society for Stem Cell Research (ISSCR), said after reading an informational packet written by Purita, available to patients on his website. "If it were subjected to a critical analysis by experts in the field, it would be dismissed as unfortunately superficial and inaccurate."
 
In case you are new to this, Daley is a "doctor" well bribed by Pharma to lie about stem cells.  His ISSCR was endowed by millions and millions of Pharma cash to perpetuate the lies about RSC and pretend that embryonic stem cells (ESC) are the future of medicine.

What murdering liars like Daley will never allow to be published (yes, he is that powerful) is that right now there are over 1500 successful RSC clinical trials completed or ongoing, at the NIH website, www.clinicaltrials.com. There are zero successful ESC trials; not to mention one horribly failed ESC trial last year.

None of that seemed to matter to Nitkowski, who said all he wanted was a chance to pitch one last season in the major leagues. CNN followed him after his injections through a grueling series of workouts. First, he had to regain his arm strength by hitting tennis balls hurled at him by a machine. Then, he had to throw a football at a moderate pace. Finally, in October, he began to throw a baseball again.
 
Nitkowski felt that his arm strength was back to normal and his fastball was back to its usual velocity. Nitkowski has converted himself into a sidearm pitcher, abandoning the customary over-the-top delivery. His specialty, he said, would be to come in briefly in the late innings of a game to get one or two left-handed batters out and the unusual pitching motion would make him more effective against lefties.
 
But finding a spot on a major league roster would be difficult, even if he were healthy and even though left-handed relief pitchers are a valuable commodity.
 
CNN Correspondent Drew Griffin talked to Nitkowski at his home in suburban Atlanta.
 
"Do you ever lay in bed and think, 'Am I delusional?'" Griffin asked.
 
"There's times where you question yourself," Nitkowski said. "Anything you want to do, if you have a passion about it, you're gonna do whatever it takes to do it. And so that's where I'm at. There's times doubt definitely creeps in."
On New Year's Day, Nitkowski found himself at a baseball stadium in Santo Domingo, capital of the Dominican Republic. He had paid his own way there to try out for a job as a reliever for one of the four teams playing in the Dominican Winter League round-robin playoffs. His agent had a friend who was also an agent in the Dominican Republic.
 
After two days of waiting, Nitkowski finally had his tryout -- and he won a job. The pay for two weeks with the Dominican League Gigantes? $2,500, less that one-fifth of what a major-league rookie makes.
Nitkowski pitched in five games during the Dominican postseason. He didn't allow a hit in his first four appearances but gave up four runs in final game there.
 
When he returned to the United States, he couldn't find any big league teams interested. He changed agents. Finally, he managed to get a tryout with the New York Mets. Again, he thought he did well but there was no contract. No return to major league baseball.
 
C.J. Nitkowski is still at home without a pitching job. He's helping coach several youth teams. He still works out and contemplates pitching in an independent league.
 
He was able to get a temporary baseball-related job. He auditioned for a role in an upcoming movie biography of Brooklyn Dodgers general manager Branch Rickey, who signed Jackie Robinson to his first major league contract. Harrison Ford will play Branch Rickey. Nitkowski will have a speaking role as a pitcher on one of the Dodgers' opponents.
 
He just hopes that it won't be his final time on the mound.
Posted: 4/21/2012 2:24:18 PM by Don Margolis | with 0 comments


Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
ireland-finally-gets.jpg

Prof Colin McGuckin, director of the newly launched Adult Stem-cell Foundation of Ireland, said debate was needed on the controversial issue for the health of Irish citizens

A world expert on adult stem cell research has warned Ireland must look to the future to protect the population.
 
Prof Colin McGuckin, director of the newly launched Adult Stem-cell Foundation of Ireland, said debate was needed on the controversial issue for the health of Irish citizens.  Prof. Mc Guckin was the ONLY stem cell doctor in the United Kingdom to tell the truth about the embryonic hoax back in 2009 and was forced out of Newcastle U. for his honesty.  He has been constantly praised by the Repair Stem Cell Institute.  We are thrilled to see this great research scientist take on those who would keep real stem cells away from those who need them.

The Vatican’s adviser on stem cell issues said like all countries in Europe, Ireland must be ready for new treatments.  Ireland has, up to now, suffered with nothing but false stem cell information available in its media, promoted by those who do not want adult stem cells to interfere with their huge profits on pills and expensive, usually dangerous treatments.
 
“We cannot simply look back and say, ‘I wish we had prepared for that’,” said Prof McGuckin. “In my career, I worked with children who would be alive today if more stem cell banks had been available.”
 
The foundation is dedicated to providing awareness and information about adult stem cells, research, development and therapies, as well as supporting people in need of or undergoing stem cell therapy.
 
It will also back the development of an all-Ireland stem cell bank and to support adult stem cell research and development.
 
Prof McGuckin believes Ireland must fund adult stem cell research and be ready to understand the socio-economic issues surrounding cellular therapy, stem cell banking, facilities provision, law and the relevant medical technology.
 
Adult stem cells are found in bone marrow, peripheral blood, umbilical cord blood, skeletal muscle, skin and teeth. They have been used to successfully treat leukaemia and related blood cancers for years.

Umbilical cord blood and bone marrow treatments have seen the highest success rate to date and can treat leukaemia, lymphoma, sickle cell disease, thalassaemia and immune deficiencies.
 
More than 70 diseases are treatable with cord blood and over 15 clinical trials are under way for new conditions.
 
Prof McGuckin said umbilical cord blood, with 130 million births per year, remains the most available stem cell source.
 
“The health of Irish citizens demands that we debate now what we can do and umbilical cord blood and adult stem cells must be part of that debate,” added the director of the Cell Therapy Research Institute in Lyon, France.
 
Prof McGuckin’s research group was the first to identify a rare group of cells with similar characteristics to embryonic stem cells and to develop them into non-blood tissues such as liver, brain and pancreas.
 
His latest clinical trial includes the use of a child’s own cord blood for the treatment of severe neonatal hypoxia, which may lead to cerebral palsy.
 
He is also developing a treatment for children with congenital bone malformations such as cleft palate, using the child’s own mesenchymal stem cells to make bone implants.
Posted: 4/18/2012 1:47:11 PM by Don Margolis | with 0 comments


Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
Yale U. doctors had to practice for months and months to perfect an impossible stem cell based surgery – and they made it work!

rebuild-a-heart.jpg

A young girl in Bridgeport, Connecticut, born with one of the most serious, life-threatening congenital heart defects known, is on her way to living a normal life thanks to Yale doctors who developed and performed the first operation of its kind in the United States.

Angela Irizarry was the first American patient to receive a tissue-engineered blood vessel made of her own natural cells.
Under normal conditions, the heart’s two ventricles collect and pump blood through the body; one sends blood to the lungs where it is mixed with oxygen and the second pumps that oxygenated blood back to the body’s circulatory system.
 
Angela Irizarry came into the world in November 2007 with one functioning ventricle and the second severely underdeveloped — an often-fatal defect known as hypoplastic left heart syndrome. With one ventricle trying to do the work of two, there is much less oxygen flowing to the body and resulting cyanosis, which are why infants born with this defect are known as “blue babies.” Without surgical intervention, 70% die in the first year.

In the past few decades surgeons have been able to save some children’s lives by implanting synthetic grafts to bypass the second ventricle. The surgery works to a certain degree, giving “blue babies” like Angela a better quality of life.  She had two such surgeries — one when she was five days old, and the second when she was eight months old. But problems inevitably arise in cases like hers, mostly stemming from the synthetic nature of the graft.
 
Yale pediatric surgeon Dr. Christopher Breuer explains: “Until now, successfully rearranging the heart’s plumbing required the use of synthetic or man-made materials to create a vascular graft or conduit. But synthetic grafts are susceptible to clotting, infection and rejection, and such complications have been the leading cause of post-operative mortality after this surgery.” Furthermore, the synthetic grafts can’t grow with the child, he adds.
 
There was a better idea, he notes, although it had not yet been approved or even tested in the United States: construct a vascular graft from a patient’s own cells — a graft that would grow with the child and would not be rejected.
 
Working with Yale pediatric cardiac surgeon Dr. Toshi Shinoka, who had developed the first version of this novel surgery and performed it on two dozen patients in Japan, and a team of Yale biomedical engineers led by Professor Mark Saltzman, Breuer’s team spent several years researching and then perfecting their surgical technique, which begins with cells, many of them stem cells, harvested from the patient’s own bone marrow. Those cells are then seeded onto a biodegradable tube-shaped polymer, a kind of scaffolding to help the cells take shape. The graft is incubated for just a few hours and then implanted.

Their thinking and the years of research that followed were in line with the expanding field of regenerative medicine, which involves the process of growing or regenerating cells and tissue so that damaged organs can function more normally.
 
When Breuer and Shinoka began experimental surgeries, they witnessed theory become reality. As they predicted, the cells on the tubular graft began to form tissue in the shape of the graft. What developed was real tissue from the patient’s own cells. Eventually, the scaffolding dissolved harmlessly, and what was left was a new blood vessel, made entirely of the patient’s own cells.

There were a few unpredictable twists along the way, however — most notably their understanding of how this was all happening. The team thought at first that the stem cells were simply regenerating a new blood vessel, since the nature of stem cells is to replicate and form specialized cells. Further scrutiny, however, revealed what was really going on: Through the inflammatory response of the body’s own immune system, the cells were simply instigating creation of a regenerated blood vessel.
 
“We were quite surprised to discover that the cells seeded onto the scaffold disappeared and were not incorporated into the new blood vessel,” Breuer said. “We had always assumed that the cells seeded onto the tissue engineering scaffold were the building blocks of the tissue that formed. Instead, our findings suggested a paradigm shift in which the seeded cells created new tissue by inducing regeneration.”
 
Breuer and his team believed they had developed a successful procedure that was ready to be tested in clinical trials on humans, but they needed approval from the U.S. Food and Drug Administration. (FDA).
 
“We were focused on making this process as safe as possible,” Breuer says. “The FDA was great to work with. They made excellent suggestions.” In November, 2009, FDA approval finally came, and Breuer and his team set out to find their first patient.
 
“We wanted to choose right patient, but find the right family too,” Breuer said. “We talked to a number of people but felt the Irizarry family was special. They asked intelligent questions and understood the potential risks and benefits. This was very important to me.”
 
Angela’s mother Claudia Irizarry was on board from the start.  She says, “I always felt positive about this. I believe in God, and that if God would send Angela to us with this condition, that he would protect her. I always believed that everything would be okay.”
 
Angela’s surgery was scheduled for August of 2011. “We did about 20 practice runs,” Breuer says. “My lab was more like a track practice than a lab. We timed everything with stopwatches, looking for ways to save every second.”
 
On the day of the surgery, Breuer recalls, everything went perfectly. The surgery was performed at Yale-New Haven Children’s Hospital by Shinoka and pediatric cardiothoracic surgeon Dr. Gary Kopf. Breuer constructed the graft, which was ready within 30 seconds of the time it took in the practice sessions.
 
As she recovered, Angela had one complication — an infection which was successfully treated but kept her in the hospital for two weeks instead of one. After that was resolved, she came home to complete her recovery. Slowly, she began to do things she couldn’t do before, becoming a normal three-year-old child who could run around and ride a bike as far as she liked. In November of 2011, Angela celebrated her fourth birthday at home, a healthy little girl who showed all signs of being able to live a normal life.
 
Angela can’t go to school right away because her immune system is not completely up to par yet (among the other problems with which she was born, she has no spleen) but Breuer is hopeful that her body will adapt, and that Angela will soon be able to do everything that other kids do.
 
Her mother says, “Maybe she will be a doctor and help other people they way she was helped.”
For Breuer and his team, there is great satisfaction. “I fully expect that she will go on to high school and college, and live a happy, healthy life,” he says.
 
Provided by Yale University
Posted: 4/17/2012 2:02:36 PM by Don Margolis | with 0 comments


Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
In general, people take too many drugs because they erroneously believe that the drugs' makers, their doctors, and the people who pay for the drugs are sincerely interested in making them healthy. The facts, though, suggest that the aforementioned groups are definitely more interested in selling drugs than they are in improving health. If health was their focus we would certainly be inundated with advice about more exercise, drinking clean water, eating organic food, avoiding processed foods, eliminated sugars, and so on. Sure, there are numerous experts who have been sounding the alarms for years, but the mainstream still seems to believe that popping a pill will make things all better - and it will do so without side effects.

I often write about beliefs and opinions, about how they are likely to be wrong. For example, people believe; that cholesterol causes heart disease, that statins improve heart health by lowering cholesterol, that depression is caused by imbalanced brain chemistry, and that the most important health issue we face is who will pay for my drugs.

It is impossible to not have beliefs and opinions. They pop into existence of themselves (likely created by conclusions we make about the experiences we have) and they are sometimes pushed on us by others. My mom instilled in me that it is wrong (sinful even) to wear a hat in church, that chocolate causes acne, that if I made a certain face it would freeze that way, and many others. Mom wasn't alone. A nun caused me to believe that red fingernail polish is the work of the devil and indicates the wearers interest in blood and gore.

We can certainly be controlled by our beliefs - and we will use them when we interact with others. While that is a fact, there is something we can do about it, especially when the beliefs are untrue and hurtful. We are, therefore, obligated to discover the truth and put aside any and all beliefs and opinions that cannot be substantiated by fact.

I am linking to an article by Dr. Dwight Lundell that prompted me to write this article. Dr. Lundell is clear about the causes of heart disease and there's ample evidence that supports his conclusions - not opinions, not beliefs, but conclusions based on evidence.

The tide is turning. I'm sounding the trumpet and so are others. I pray our sound becomes deadening and that there's a mass migration away from drugs, surgery, and radiation treatments. While there may certainly be roles for those things at times, we can not depend on them for health or longevity. I care about the future because my grandchildren and their grandchildren will be living there. They have a right to life, liberty, and the pursuit of happiness and they shouldn't have to live with drugs, radiation, and surgery merely because so many people wrongly believe in those things.
Posted: 4/3/2012 4:24:31 PM by Don Margolis | with 0 comments


Recent posts

No recent posts

Syndication

RSS
Bookmark this page to:Add to Twitter Add to Newsvine Add to MySpace Add to Link-a-Gogo Add to Multiply Add to MyAOL Add to Diigo Add to Yahoo Bookmarks Add to Yahoo MyWeb Add to Facebook Add to Mister Wong Add to Terchnorati Add to Segnalo Add to Digg Add to Google Bookmarks Add to Reddit Add to Faves Add to Blogmarks Add to StumbleUpon Add to Delicious